CPA joined 53 national associations in supporting the No Industrial Restrictions in Secret (NO IRIS) Act of 2024 (S. 3724/H.R. 7284) this week. The bill seeks to prohibit EPA from using Integrated Risk Information System (IRIS) assessments for regulatory decisions. The IRIS program, which lacks Congressional authorization, has previously influenced some of EPA’s chemical use restrictions. CPA supports this legislation to limit the potential for the formaldehyde IRIS assessment to be used to negatively impact the manufacturing and use of composite panels. Although the bill’s passage this year is unlikely, it helps raise awareness of the issue in Congress. See Letter of Support and NO IRIS bill. More Info: Andy O’Hare